THYME AND CARVACROLL Nanoparticle Effect on Fungi

Assiut University

Status: Completed

Conditions: Aspergillosis

Treatments: Other: silver nanoparticle

Study type: Observational

Funder types: Other

Identifiers

NCT04431804

wwww

Details and patient eligibility

About

Invasive Aspergillosis (IA) has increasingly been recognized as an emerging disease of non-neutropenic patients and in patients admitted to the ICU, even in the absence of an apparent predisposing immune-deficiency, with incidence ranges from 0.3% to 5.8% with an overall mortality rate exceeding 80%.

Enrollment: 210 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• intensive care patients

Exclusion criteria

• none